Mechanism of Eukaryotic Translation Termination
Mechanism of Eukaryotic Translation Termination
批准号:
7995246
负责人:
David M. Bedwell
金额:
$29.84万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-06-01 至 2012-11-30
关键词:
Biological AssayCellsComplexCouplesDataDiseaseGenesGeneticGoalsGuanosine TriphosphateHalf-LifeLengthMediatingMessenger RNAModelingMutationOrganismPeptidyltransferasePhasePoly(A) TailProcessProtein BiosynthesisProteinsRelative (related person)ReportingRibosomesStagingTechnical ExpertiseTerminator CodonTestingTherapeuticTranslation ProcessTranslationsYeastsbasemRNA Stabilitynovelpolypeptideprematurerelease factorresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Translation termination is the final stage of protein synthesis. It includes at least two essential functions, stop codon recognition and polypeptide chain release. In eukaryotic organisms, the class I release factor eRF1 recognizes each of the three termination codons (UAA, UAG, and UGA) and mediates release of the nascent polypeptide chain. The class II release factor eRF3 assists the termination process in a GTP-dependent manner. The long-term goal of this project is to better understand the process of translation termination so therapeutic strategies aimed at the suppression of disease-causing premature stop mutations can be developed. The eRF1 protein contains three discrete domains. A consideration of structural and genetic data led to the proposal that domain 1 mediates stop codon recognition; domain 2 interacts with the peptidyl transferase center of the ribosome to facilitate polypeptide chain release; and domain 3 mediates the interaction between eRF1 with eRF3. Competing models argue that either the TASNIKS motif or the YCF motif in domain 1 is critical for stop codon recognition. The first aim of this proposal will identify key residues of eRF1 domain 1 involved in stop codon recognition to test the relative merits of these competing models. The yeast SUP45 gene encodes eRF1. We recently discovered that the half-life of the SUP45 mRNA is regulated by the efficiency of the termination process. This mechanism leads to an increase in the eRF1 protein level when termination is compromised. The second aim of this proposal will test this model and explore how this novel regulatory mechanism controls SUP45 mRNA and eRF1 protein levels. We recently found that the previously uncharacterized protein Tpa1p influences the efficiency of translation termination, mRNA poly(A) tail length, and mRNA half-life in yeast cells. This led us to propose a model in which Tpa1p couples translation termination to the deadenylation of cellular mRNAs. The third aim of this proposal will test various aspects of this model so we can better understand the important interplay between translation termination and mRNA stability.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1002/wrna.95
发表时间:
2011-11
期刊:
WILEY INTERDISCIPLINARY REVIEWS-RNA
影响因子:
7.3
作者:
[Keeling, Kim M., Bedwell, David M.]
通讯作者:
Bedwell, David M.
DOI:
10.1261/rna.045211.114
发表时间:
2015-05
期刊:
RNA (New York, N.Y.)
影响因子:
--
作者:
[Kelly SP, Bedwell DM]
通讯作者:
Bedwell DM
New Nonsense Suppression Drugs to Treat MPS I
-
批准号:8842247
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2014
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:7997463
-
项目类别:
-
资助金额:$4.38万
-
财政年份:2009
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:7340377
-
项目类别:
-
资助金额:$31.72万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
UAB CFRC Administrative Core
-
批准号:10673354
-
项目类别:
-
资助金额:$13.96万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:8015606
-
项目类别:
-
资助金额:$31.08万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
UAB CF Research and Translation Core Center
-
批准号:10673353
-
项目类别:
-
资助金额:$111.38万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:7179609
-
项目类别:
-
资助金额:$31.72万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Animal Models Core
-
批准号:8320678
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:7560341
-
项目类别:
-
资助金额:$31.72万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
UAB CF Research and Translation Core Center
-
批准号:10468801
-
项目类别:
-
资助金额:$111.37万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Mouse Models Core
-
批准号:7288652
-
项目类别:
-
资助金额:$16.12万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Animal Models Core
-
批准号:8451289
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Core B - Animal and Preclinical Models Core
-
批准号:10246451
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Animal Models Core
-
批准号:8851578
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Core B - Animal and Preclinical Models Core
-
批准号:10468805
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:7761315
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:7067093
-
项目类别:
-
资助金额:$27.4万
-
财政年份:2003
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:7371536
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2003
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:7534977
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2003
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:6897183
-
项目类别:
-
资助金额:$28.06万
-
财政年份:2003
-
负责人:David M. Bedwell
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: